Point-of-Care Ultrasound Is the Quiet Revolution in Diagnostics
Dr. Dereck Mush, MD, MBA
What they do
Evvy provides an at-home vaginal microbiome test using metagenomic next-generation sequencing. The company offers individuals detailed breakdowns of their vaginal bacteria and yeast, alongside access to clinical coaching, customized treatment recommendations, and educational resources to address chronic vaginal infections.
The record
- Vertical
- Women's Health
- Sub-segment
- Vaginal microbiome diagnostics
- Product type
- Diagnostics
- Stage
- Series A
- Headquarters
- New York, USA
- Region
- North America
- Founded
- 2021
- Total funding
- $22M raised
Notable investors: Left Lane Capital, General Catalyst, Human Ventures, Virtue.
Also in Women's Health
Related on The Signal
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The 8 Best AI Diagnostic Tools of 2026
AI diagnostics stopped being experimental. These eight tools are FDA-cleared, deployed at scale, and quietly changing how disease gets found.
Dr. Dereck Mush, MD, MBA
Mobile Optical Diagnostics: Ending the Multibillion-Dollar Emergency Vertigo Workup
Dr. Dereck Mush, MD, MBA
Decentralizing Syndromic PCR: The Point-of-Care Molecular Margin War
Dr. Dereck Mush, MD, MBA